On the FDA’s docket for the back half of September is Merck’s proposed subcutaneous formulation of its blockbuster cancer ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain ...

Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...

The Emirates Drug Establishment participated in the 3rd Meeting of Heads of National Drug Regulatory Authorities of the Organization of Islamic Cooperation (OIC), underscoring its role in advancing ...

Secondary progressive multiple sclerosis (SPMS) can be active or inactive. Learn about the differences and how it impacts treatment.